BEUDAMED
    FDA Adverse Event Injury Summary report: N

    THINLINE II

    MDR report key: 3211666 · Received July 8, 2013

    Report

    Report Number
    2124215-2013-08131
    Event Type
    Injury
    Date Received
    July 8, 2013
    Date of Event
    April 18, 2013
    Report Date
    May 8, 2013
    Manufacturer
    GUIDANT ANGLETON/ST. PAUL
    Product Code
    NVN
    Adverse Event
    Yes
    Product Problem
    Yes
    Report Source
    Manufacturer report
    Reporter Occupation
    PHYSICIAN

    Narratives

    Additional Manufacturer Narrative · 1

    AS THE LEAD WAS NOT ABLE TO BE RETURNED, CLINICAL OBSERVATIONS CANNOT BE CONFIRMED. AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.

    Description of Event or Problem · 1

    BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THIS RIGHT VENTRICULAR (RV) LEAD EXHIBITED OVERSENSING THAT RESULTED IN A LOSS OF PACING. THE LEAD WAS SURGICALLY ABANDONED AND REPLACED. NO ADVERSE PATIENT EFFECTS WERE REPORTED.

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    309106 THINLINE II IMPLANTABLE LEAD NVN GUIDANT ANGLETON/ST. PAUL 430-25

    Patients

    Seq Age Sex Outcome Treatment
    1 72 YR Hospitalization| L| R 2360L| 432-04| SESR01| 4471| 430-25